Metacrine
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases.
1
Funding Rounds
$65.0m
Money raised
Overview
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases.
-
Website:
- Business model: B2C
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri He**** | - | - | |
| Am** Na**** |
|
- | linkedin twitter |
| Ju*** C. Ow*** | - | - | - |
| Jo** Mc**** | - | - | - |
| Pr Kl | - | - | - |
| Je** Jo**** | - | - | - |
| An**** Gu*** | - | - |
Funding series
Funding Series Analysis
The company Metacrine has raised a total of $65m in funding over 1 rounds.
Key Insights:
- Metacrine Series C round, June 2018: $65m
Metacrine Series C round, June 2018
$65m
Industries
Metacrine is active in the following industries: